Mumbai A division bench of the Delhi High Court on Wednesday ordered Dr Reddy's Labs to file its reply to the injunction petition moved by Danish drug maker Novo Nordisk for its blockbuster weight-loss drug semaglutide, which is sold under the brand name Wegovy.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
You may also like
Coldplay concert fallout: Astronomer confirms HR head's resignation after viral kiss cam video, days after CEO Andy Byron stepped down
Princess Diana's 'secret daughter' killed friend and cat after thinking she was Jesus
Highlights from Day 2 of the Manchester Test: India vs England
Coldplaygate: Astronomer HR head Kristin Cabot resigns days after CEO Andy Byron stepped down
New train stations will allow tourists to explore popular UK holiday destination
